News | April 01, 2023
ProBioGen delivers strong 2022 performance
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)